Sched.com Conference Mobile Apps
SLAS 2019 Americas Sample Management Symposium
has ended
Create Your Own Event
SLAS 2019 Americas Sample Management Symposium
-
Saved To
My Schedule
Get more information at ---->
www.slas.org/events/2019-slas-americas-sample-management-symposium/
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Chairs
Sponsors
Exhibitors
Attendees
Map
Search
or browse by date + venue
Lightning Session
Networking
Opening/Closing Remarks and Keynote
Posters
Registration
Session 1: Enabling Drug Discovery: Target Validation to PreClinical
Session 2: Innovative Technology and Process Optimization
Session 3: Enabling New Medicines: From Candidate to the Clinic
Session 4: The Common Treads Across All Sample Types. Challenges of Sample Management Quality and Compliance
Vendor Snapshot
Popular
menu
Menu
Schedule
Speakers
Chairs
Sponsors
Exhibitors
Attendees
Map
Search
Featured Speakers
Juan Alvarez, Merck and Co.
Merck and Co.
AVP Computational and Structural Chemistry
Speakers
S
Sujeegar Jeevanandam
Zifo RnD Solutions
Principal Consultant
CA
Carla Alpert
Merck
Senior Scientist
JA
Jeff Andrews
AstraZeneca
Sr Scientist
Pierre Baillargeon
The Scripps Research Institute
Senior Robotics Engineer
MB
Monica Betancur
Merck
Senior Scientist
KN
Kristen Nailor, B.S. Biochemistry
Genentech
Scientific Manager
Rebecca Blanchard, Ph.D.
CRISPR Therapeutics, Cambridge, MA
Vice President, Translational Pharmacology
LB
Lindsey Bonicki
Astrazeneca
DC
David Calle
AstraZeneca
Marta Castelhano
Cornell University
Cornell Biobank Director
JC
Jefferson Chin, B.Sc, MBA
Pfizer
Senior Scientist
MG
Michelle Galante
Evotec
Group Leader, Operations
Sara Grab
GSK
Investigator
Jeff Gross
GSK
Director of Screening, Profiling and Mechanistic Biology
Mark Gulbronson, MS, MA
Amgen
Director Research Operations
CJ
Chatura Jayakody
Accent Therapeutics
Manager, Research Operations
SJ
Sean Johnston
Biogen
Sr Associate Scientist
Zofia Jordon
Pistoia Alliance
Chair of the Controlled Substance Expert Group
Jean-Claude Marshall
Pfizer
Head of Clinical Biomarker Technologies in Early Clinical Development
DM
Duncan McNicol
Merck
Associate Director
JS
John Smutko
Jessie Bin Song, BS
Merck & Co., Inc.
Director of Controlled Substance Compliance
Shaun Stauffer, Ph.D.
Cleveland Clinic
Director, Cleveland Clinic Center for Therapeutics Discovery
ES
Evelyn Stevenson
Brooks Life Sciences
Senior Product Manager
MB
Monica Betancur, BS Medical Technology
Merck
Senior Scientist
NT
Nadia Tournier
GSK
Biological Licensing Coord
VV
Viral Vyas, MSIS
Bristol Myers Squibb
Lead IT Business Partner Translational Medicine
Nicolas Zorn, Ph.D.
Hoffmann La Roche
Head Compound Library Enhancement and Logistics